Barbieri M A, Hoffenberg S, Roberts R, Mukhopadhyay A, Pomrehn A, Dickey B F, Stahl P D
Department of Cell Biology and Physiology, Washington University, School of Medicine, St. Louis, Missouri 63110, USA.
J Biol Chem. 1998 Oct 2;273(40):25850-5. doi: 10.1074/jbc.273.40.25850.
Early endosome fusion, which has been extensively characterized using an in vitro reconstitution assay, is Rab5-dependent. To examine the requirement for Rab5 on both fusion partners, we prepared cytosol and endosomes depleted of Rab5. Unlike control cytosol, Rab5-depleted cytosol was only marginally active in the in vitro endosome fusion. However, fusion could be restored by the addition of wild-type Rab5 or Rab5 D136N, a mutant whose nucleotide specificity favors xanthine over guanine. The addition of Rab5 D136N restored fusion only in the presence of XTP. In the absence of XTP or in the presence of XDP, Rab5 D136N failed to restore fusion. When fusion was carried out with endosomal vesicles depleted of Rab GTPases (by preincubation of vesicles with GDP dissociation inhibitor), together with cytosol immunodepleted of Rab5, fusion was virtually absent. We then used immunodepleted cytosol and GDP dissociation inhibitor-treated vesicles to determine whether Rab5 is required by both fusion partners. Using separate sets of endosomal vesicles, we found that priming both sets of Rab5-depleted vesicles with Rab5 Q79L, a GTPase-defective mutant, substantially stimulated endosome fusion. Priming one set of vesicles with Rab5 Q79L and a second set of vesicles with Rab5 S34N failed to activate fusion. When both sets of Rab5-depleted vesicles were primed with Rab5 D136N supplemented with XTP, endosome fusion was stimulated, similar to that observed with Rab5 Q79L. However, when one set of vesicles was preincubated with Rab5 D136N plus XTP and the second set with Rab5 D136N and XDP, no stimulation of fusion was observed. We conclude that Rab5-GTP is required on both fusion partners for docking and fusion of early endosomes. To confirm the fusion of Rab5-GTP-positive vesicles in vivo, we expressed GFP-Rab5 Q79L in fibroblasts and observed fusion of Rab5-positive vesicles. We failed to record fusion of Rab5-positive vesicles with Rab5-negative vesicles. We conclude that Rab5-GTP is required on both sets of endosomes for fusion in vitro and in living cells.
早期内体融合已通过体外重组试验得到广泛表征,它依赖于Rab5。为了研究Rab5对两个融合伙伴的需求,我们制备了不含Rab5的胞质溶胶和内体。与对照胞质溶胶不同,不含Rab5的胞质溶胶在体外内体融合中活性极低。然而,通过添加野生型Rab5或Rab5 D136N(一种核苷酸特异性更倾向于黄嘌呤而非鸟嘌呤的突变体)可恢复融合。仅在存在XTP的情况下,添加Rab5 D136N才能恢复融合。在不存在XTP或存在XDP的情况下,Rab5 D136N无法恢复融合。当用不含Rab GTP酶的内体囊泡(通过将囊泡与GDP解离抑制剂预孵育)与免疫去除Rab5的胞质溶胶进行融合时,几乎没有融合发生。然后我们使用免疫去除的胞质溶胶和经GDP解离抑制剂处理的囊泡来确定两个融合伙伴是否都需要Rab5。使用单独的内体囊泡组,我们发现用GTP酶缺陷型突变体Rab5 Q79L对两组不含Rab5的囊泡进行启动,可显著刺激内体融合。用Rab5 Q79L对一组囊泡进行启动,并用Rab5 S34N对另一组囊泡进行启动,无法激活融合。当两组不含Rab5的囊泡都用补充有XTP的Rab5 D136N进行启动时,内体融合受到刺激,类似于用Rab5 Q79L观察到的情况。然而,当一组囊泡用Rab5 D136N加XTP进行预孵育,另一组用Rab5 D136N和XDP进行预孵育时,未观察到融合刺激。我们得出结论,早期内体的对接和融合需要两个融合伙伴上都有Rab5-GTP。为了在体内证实Rab5-GTP阳性囊泡的融合,我们在成纤维细胞中表达了GFP-Rab5 Q79L,并观察到Rab5阳性囊泡的融合。我们未能记录到Rab5阳性囊泡与Rab5阴性囊泡的融合。我们得出结论,在体外和活细胞中,两组内体融合都需要Rab5-GTP。